The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Dining car stewards vote for a better future
- Railroad discipline increases – DIPP can see you through
- Longtime ally of union workers elected minority leader of Railroads, Pipelines, and Hazardous Material Subcommittee
- FRA Administrator Amit Bose Honored as He Steps Down
- PRESS RELEASE: SMART-TD Helps Secure Crucial Win For Worker Safety
- Railroad Retirement Board Announces Enactment of Railroad Employee Equity and Fairness Act (REEF)
- Metra Workers Receive High Praise From Chicagoans
- Hotel Registration Deadline Approaching For Dallas Regional Training!
- Mercer County gains a new champion to fight for transit access: SMART-TD Brother Ron Sabol
- Local 1706 ratifies new agreement with Zum Transportation